Home
Categories
States
Check Your Home
Home
/
Categories
/
Medications & Supplements
/
Prescription Drugs
Prescription Drugs
All
Prescription Drugs
(2121)
Over-the-Counter
(230)
Dietary Supplements
(165)
Topical Products
(406)
Veterinary Medicines
(64)
2,121 recalls
Show
24
48
96
per page
FDC
Medium Risk
FDA Drug
Leading Pharma Ciprofloxacin Eye Drops Recalled for Defective Bottles
Distributed nationwide
136,181 units affected
Recalled
Jan 3, 2025
Added
Mar 20, 2026
Boothwyn Pharmacy
Medium Risk
FDA Drug
Boothwyn Pharmacy Semaglutide and Fluorescein Recalled for Subpotency
Distributed nationwide
Sold at Boothwyn Pharmacy
Recalled
Aug 29, 2025
Added
Mar 20, 2026
Harbin Jixianglong Biotech
Medium Risk
FDA Drug
Harbin Jixianglong Semaglutide Recalled for Process Validation Failures
Distributed nationwide
Sold at Compounding pharmacies, Wholesalers
Bacterial endotoxins contamination
Recalled
Mar 2, 2026
Added
Mar 20, 2026
Nostrum Laboratories
Medium Risk
FDA Drug
Nostrum Laboratories Inc: Metformin Hydrochloride ER Tablets Recalled for NDMA Impurity
Distributed nationwide
Sold at Pharmacies nationwide
N-Nitrosodimethylamine (NDMA) contamination
Recalled
Feb 4, 2021
Added
Mar 20, 2026
Direct Rx
Medium Risk
FDA Drug
Direct Rx Duloxetine D/R Recalled for Nitrosamine Impurity
Distributed nationwide
Sold at Pharmacies, Breckenridge Pharm., Inc.
Nitrosamine Drug Substance Related Impurity contamination
Recalled
Aug 4, 2025
Added
Mar 20, 2026
Lannett
Medium Risk
FDA Drug
Niacin Extended-Release Tablets Recalled for Failed Dissolution
Distributed nationwide
Sold at pharmacies, wholesalers
46,848 units affected
Recalled
Oct 22, 2025
Added
Mar 20, 2026
Amerisource Health Services
Medium Risk
FDA Drug
American Health Packaging Indomethacin Capsules Recalled for cGMP Deviations
Distributed nationwide
Sold at American Health Packaging
Recalled
Jun 2, 2025
Added
Mar 20, 2026
Torrent Pharma
Medium Risk
FDA Drug
Fluoxetine Tablets Recalled for Excessive N-Nitroso Fluoxetine Impurity
Distributed nationwide
Sold at Retail Pharmacies
N-Nitroso Fluoxetine contamination
Recalled
Jun 2, 2025
Added
Mar 20, 2026
Noven Pharmaceuticals
Medium Risk
FDA Drug
Daytrana Methylphenidate Patches Recalled for Defective Delivery System
Distributed nationwide
Sold at Pharmacies
Recalled
May 20, 2022
Added
Mar 20, 2026
Mylan Pharmaceuticals
Medium Risk
FDA Drug
Mylan Pharmaceuticals Inc.: Valsartan and Amlodipine Tablets Recalled for Potential NDEA Impurity
Distributed nationwide
Sold at Pharmacies, Healthcare providers
N-nitrosodiethylamine, NDEA contamination
Recalled
Dec 11, 2018
Added
Mar 20, 2026
Medium Risk
FDA Drug
Leiters Health Syringes Recalled for Potential Sterility Loss
Distributed nationwide
Sold at Wholesalers, Hospitals +1 more
Potential microbial contamination due to lack of sterility assurance contamination
Recalled
Apr 18, 2025
Added
Mar 20, 2026
Medium Risk
FDA Drug
Glenmark Rizatriptan Benzoate Tablets Recalled for Impurity Levels
Distributed nationwide
Sold at Wholesalers, Retail Pharmacies
N-Nitroso Desmethyl Rizatriptan contamination
Recalled
Jun 4, 2024
Added
Mar 20, 2026
Camber Pharmaceuticals
Medium Risk
FDA Drug
Camber Pharmaceuticals Inc: Losartan Potassium Tablets Recalled for Impurity and CGMP Deviations
Distributed nationwide
Sold at Pharmacies
N-Nitroso N-Methyl 4-amino butyric acid (NMBA) contamination
Recalled
Mar 21, 2019
Added
Mar 20, 2026
Safecor Health
Medium Risk
FDA Drug
Haloperidol Lactate Injection Recalled for Incorrect RFID Tag Labels
Sold in Massachusetts
Sold at Mylan Institutional LLC, Safecor Health LLC +1 more
Recalled
Dec 2, 2025
Added
Mar 20, 2026
Medium Risk
FDA Drug
Amneal Pharmaceuticals of New York, LLC: Metformin Hydrochloride Extended-Release Tablets Recalled for NDMA Impurity
Distributed nationwide
Sold at authorized distributors, pharmacies
N-Nitrosodimethylamine (NDMA) contamination
Recalled
Jun 25, 2020
Added
Mar 20, 2026
ProRx
Medium Risk
FDA Drug
ProRx Semaglutide and Tirzepatide Recalled for Sterility Concerns
Distributed nationwide
Sold at ProRx LLC
16,604 units affected
Recalled
Sep 5, 2024
Added
Mar 20, 2026
Dr. Reddy's Laboratories
Critical Risk
FDA Drug
Javygtor and Sapropterin Dihydrochloride Recalled for Sub-potency
Distributed nationwide
Sold at Pharmacies
19,734 units affected
Recalled
May 6, 2024
Added
Mar 20, 2026
Medium Risk
FDA Drug
Mesalamine Extended-Release Capsules Recalled for Failed Dissolution
Distributed nationwide
Sold at Retail Pharmacies
54,960 units affected
Recalled
Feb 23, 2024
Added
Mar 20, 2026
QuVa Pharma
Medium Risk
FDA Drug
QuVa Pharma Epidural Injection Cassettes Recalled for Sterility Risks
Distributed nationwide
Sold at Institutional Use, Medical Offices +1 more
Lack of Assurance of Sterility contamination
Recalled
Mar 25, 2025
Added
Mar 20, 2026
Fresenius Kabi Compounding
Medium Risk
FDA Drug
Fresenius Kabi Sterile Injectable Drugs Recalled for Lack of Sterility
Distributed nationwide
Sold at Hospitals, Infusion centers +1 more
14,593 units affected
Recalled
Feb 12, 2026
Added
Mar 20, 2026
Padagis US
Medium Risk
FDA Drug
Trospium Chloride Extended-Release Capsules Recalled for Tablet Defects
Distributed nationwide
Sold at Nationwide retailers, Pharmacies
Recalled
Dec 5, 2023
Added
Mar 20, 2026
Teva Pharmaceuticals USA
Medium Risk
FDA Drug
Metoclopramide Tablets Recalled for Potential Foreign Tablets or Capsules
Distributed nationwide
Sold at Pharmacies
Foreign tablets/capsules contamination
Recalled
Jun 20, 2025
Added
Mar 20, 2026
Bryant Ranch Prepack
Low Risk
FDA Drug
Cephalexin Oral Suspension Recalled for Labeling Errors
Distributed nationwide
Recalled
Jun 4, 2024
Added
Mar 20, 2026
Medium Risk
FDA Drug
Glenmark and Northstar Diltiazem HCl ER Capsules Recalled for Impurities
Distributed nationwide
Sold at Pharmacies
N-nitroso-Desmethyl-Diltiazem contamination
Recalled
Dec 3, 2024
Added
Mar 20, 2026
Previous
1
...
84
85
86
...
89
Next
Search
Risk Level
Agency
State
Filters